University of Sulaimani Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2011
NCT02429323
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

ALI KAMAL M. SAMI | Clinical Pharmacy Department/ College of Pharmacy/University of Sulaimani/ Kurdistan Region-Iraq. | College of Dentistry, University of Sulaimani | College of Medicine, University of Sulaimani | Department of Pharmacology and Toxicology-College of Pharmacy-University of Sulaimani | University of Sulaimani

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7